<DOC>
	<DOC>NCT01185717</DOC>
	<brief_summary>The objective of the study is to estimate the prevalence of anti-JCV antibodies in multiple sclerosis (MS) participants.</brief_summary>
	<brief_title>JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS)</brief_title>
	<detailed_description>This is a cross-sectional, multi-center, multi-national, epidemiological study to estimate the prevalence of anti-JCV antibody in MS participants. This study will provide an estimate of the prevalence of anti-JCV antibody in the MS population and will investigate inter-country differences.</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Key All candidates for this study must have the ability to understand the purpose of the study and provide signed and dated informed consent. All patients with a diagnosis of Multiple Sclerosis (MS) of any type, irrespective of their treatment, are eligible to participate once. Key NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>